These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 5240758)
1. Leukocyte histidine decarboxylase: properties and activity in myeloproliferative disorders. Krauss S; Gilbert HS; Wasserman LR Blood; 1968 Jun; 31(6):699-709. PubMed ID: 5240758 [No Abstract] [Full Text] [Related]
2. [The activity of the alkaline phosphatase of neutrophils in myeloproliferative diseases]. Vakulenko AD; Shubich MG Ter Arkh; 1966 Feb; 38(2):66-9. PubMed ID: 5235224 [No Abstract] [Full Text] [Related]
3. Diagnosis and management of myeloproliferative disorders. Laszlo J; Huang AT Curr Probl Cancer; 1977 Jul; 2(1):1-42. PubMed ID: 268266 [No Abstract] [Full Text] [Related]
4. A study of histamine in myeloproliferative disease. Gilbert HS; Warner RR; Wasserman LR Blood; 1966 Dec; 28(6):795-806. PubMed ID: 5959473 [No Abstract] [Full Text] [Related]
10. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders. Gingold N Rev Roum Med; 1974; 12(1):15-8. PubMed ID: 4533361 [No Abstract] [Full Text] [Related]
12. [Diagnostic and pathogenetic significance of some cytogenetic and cythochemical findings (leukocyte alkaline phosphatase) in systemic hemopathies with myeloproliferative tendencies]. Cacciola E; Giustolisi R Haematologica; 1970; 55(5):311-32. PubMed ID: 4995787 [No Abstract] [Full Text] [Related]
13. [Leukocytic alkaline phosphatase in acute leukemia and chronic myeloproliferative syndrome]. Zittoun R; Reyes F; Guillerm M; Bousser J Sem Hop; 1968 Jun; 44(31):2085-91. PubMed ID: 4300453 [No Abstract] [Full Text] [Related]
14. Use of glucose-6-phosphate dehydrogenase markers to study human myeloproliferative disorders. Fialkow PJ Haematol Blood Transfus; 1979; 23():53-8. PubMed ID: 296115 [No Abstract] [Full Text] [Related]
15. Observations on the in vitro growth of peripheral leucocytes from patients with myeloproliferative disorders. Pegrum GD Br J Haematol; 1966 Nov; 12(6):689-96. PubMed ID: 5224278 [No Abstract] [Full Text] [Related]
16. Quantitation of RNA-dependent platelet DNA polymerase in patients with myeloproliferative disorders. Strayer DR; Brodsky I; Caranfa MJ; Gillespie DH Br J Haematol; 1982 Mar; 50(3):521-30. PubMed ID: 6175335 [TBL] [Abstract][Full Text] [Related]
17. [Leukocyte alkaline phosphatase and glucose-6-phosphate-dehydrogenase of the erythrocytes in differential diagnosis of chronic myeloproliferative diseases (author's transl)]. Hennemann HH; Schief A Med Klin; 1974 Aug; 69(34):1359-63. PubMed ID: 4530151 [No Abstract] [Full Text] [Related]
18. [Behavior of alkaline leukocytephosphatase in pancytopenias]. Weeissel M Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(3):245-52. PubMed ID: 4172017 [No Abstract] [Full Text] [Related]
19. Platelet alkaline phosphatase: normal values and variations in myeloproliferative syndromes. Ansell BF; Scott RB Proc Soc Exp Biol Med; 1969 Apr; 130(4):1119-21. PubMed ID: 5779987 [No Abstract] [Full Text] [Related]